| Murine Bronchoalveolar Lavage
|
|
Author:
Date:
2017-05-20
[Abstract] A basic Bronchoalveolar lavage (BAL) procedure in mouse is described here. Cells and fluids obtained from BAL can be analyzed by Hema3-staining, immunostaining, Fluorescence-activated cell sorting (FACS), PCR, bicinchoninic acid protein assay, enzyme-linked immunosorbent assay (ELISA), luminex assays, etc., to examine the immune cells, pathogens, proteins such as cytokines/chemokines, and the expression levels of inflammation-related and other genes in the cells. This will help to understand the underlying mechanisms of these lung diseases and develop specific and effective drugs.
[摘要] 这里描述了小鼠中基本的支气管肺泡灌洗（BAL）程序。可以通过Hema3染色，免疫染色，荧光激活细胞分选（FACS），PCR，二金鸡宁酸蛋白测定，酶联免疫吸附测定（ELISA），luminex检测等来分析从BAL获得的细胞和液体。 / em>，以检查免疫细胞，病原体，蛋白质如细胞因子/趋化因子，以及细胞中炎症相关基因和其他基因的表达水平。这将有助于了解这些肺部疾病的潜在机制，并开发具体有效的药物。
背景 支气管肺泡灌洗（BAL）是通常用于诊断肺部疾病（包括肺癌）的简单且典型的方法（Daubeuf和Frossard，2012）。它用于采样肺组分，以确定肺中的蛋白质组成，免疫细胞和病原体。肺部慢性炎症在肺癌起始和进展中起关键作用。为了阐明肺肿瘤发生的炎症的潜在机制，我们的实验室使用了一种基本的BAL方案来确定肺部免疫反应（Qu等人，2015; Zhou等）。 ，2015; Sun等人，2016; Zhou等人，2017）。
|
|
|
| Coculture between hMADS and Mouse Adult CM
|
|
Author:
Date:
2014-07-20
[Abstract] Heart failure occurring after acute myocardial infarction (MI) is among the main causes of death in western countries. Cell therapies, particularly those based on mesenchymal stem cells (MSC), represent one of the most promising approaches to repair damaged heart tissues. Several reports have provided evidences that injection of mesenchymal stem cells improved heart function following myocardial infarction (Shake et al., 2002; Zimmet and Hare, 2005; Zeng et al., 2007). Nevertheless, the mechanism(s) by which MSC exert their therapeutic action is far from being understood, and further knowledges in this field are required especially to optimize efficiency of current cardiac cell therapies. To assess the regenerative mechanisms developed by MSC in vitro, we ...
[摘要] 急性心肌梗死（MI）后发生的心力衰竭是西方国家死亡的主要原因。细胞疗法，特别是基于间充质干细胞（MSC）的那些，代表了修复受损心脏组织的最有希望的方法之一。几个报道提供了证据，注射间充质干细胞改善了心肌梗塞后的心脏功能（Shake等人，2002; Zimmet和Hare，2005; Zeng等人， 2007）。然而，MSC发挥其治疗作用的机制远未被理解，并且尤其需要在该领域中的进一步知识以优化当前心脏细胞治疗的效率。为了评估由MSC在体外形成的再生机制，我们开发了上述方法，其预期模拟梗塞心脏的典型微环境。该方法包括处于不良状态的小鼠终末分化心肌细胞与本文用作MSC模型的人多能脂肪来源干细胞（hMADS细胞）之间的物种错配共培养物。
|
|
|